Via the SCFA receptors, SCFAs reportedly modulated the release of proinflammatory cytokines such as tumor necrosis factor α and interleukin 6 that may alter insulin sensitivity and contribute to the development of persistent chronic inflammation86,87, which has been implicated in cancer development including that of HCC88. The gene discussed is INS; the disease is cancer.